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Randomized controlled trial of ambulatory oxygen
and an ambulatory ventilator on endurance exercise
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S. M. REVILL, S. J. SINGH AND M. D. L. MORGAN
Department of Respiratory Medicine, Glenfield Hospital, Leicester, LE3 9QP, U.K.
In a prospective, randomized study we examined the eect of (i) ambulatory oxygen and (ii) a portable, inspiratory
pressure support (IPS) device on the endurance shuttle walk test (ESWT) in patients with severe chronic obstructive
pulmonary disease (COPD). Ten outpatients [median (range) FEV1 0.60 l (0.35, 1.45)] performed the ESWT under
five test conditions: baseline walk (no assistance), IPS at 14 cmH2O from a portable ventilator (the HIPPY, Friday
Medical, U.K.), sham IPS (58 cmH2O), ambulatory oxygen at 2 lmin
71, and sham oxygen (carrying the portable
oxygen cylinder and breathing air). There were significant improvements in the ESWT with ambulatory oxygen, but
a negative eect with the HIPPY device [mean (SD) time: baseline 172 (48) sec; oxygen 242 (62) sec; HIPPY 84 (35)
sec]. The ESWT appeared sensitive to the eect of cylinder weight although dierences in endurance capacity were
not significant [sham oxygen 151 (45) sec]. The ESWT was sensitive to the acute application of oxygen,
demonstrating a beneficial eect on endurance performance in patients with severe COPD. The ESWT could form
the basis of a standardized assessment for ambulatory oxygen.
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The role of ambulatory oxygen in improving exercise
tolerance, daily activity and exertional breathlessness in
patients with COPD is unclear. There are a number of
short-term studies which have examined the eects of
ambulatory oxygen (1–6) and recent guidelines suggest that
the patient assessment should contain a field walking test
(7). Laboratory tests have demonstrated increased cycle
ergometer and treadmill endurance time (1,3), whilst
improvements in the 6 and 12 min walk distance is variable
and may be influenced by cylinder weight or the placebo
eect (2, 4–6). The evidence for the benefits of ambulatory
inspiratory pressure support (IPS) on exercise capacity and
breathlessness remains sparse. A study from O’Donnell et
al. (8) demonstrated increased cycle endurance time with
continuous positive airway pressure, whilst Keilty et al. (9)
have shown increased treadmill walking time with non-
invasive IPS.
Formal assessment of the benefit of either ambulatory
oxygen or IPS requires a reliable and sensitive measure of
functional capacity which is capable of detecting clinically
important change. In a study which examined portable
liquid oxygen, a semi-standardized, field endurance walkReceived 17 January 2000 and accepted in revised form 8 March
2000.
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0954-6111/00/080778+06 $35?00/0test was found to be more sensitive than the 6 min walk
distance and recommended as a practical method of
assessment (2). Recently we have described a standardized
endurance shuttle walk test (ESWT) which provides the
same relative exercise intensity for all patients and, since it
has externally imposed pacing, avoids the variations of self-
paced tests. The test is repeatable after one practice walk
and is strongly sensitive to pulmonary rehabilitation (10).
The recent U.K. Guidelines (7) suggest the benefits of
ambulatory oxygen should be established in the individual
patient prior to prescription. Ideally this requires a simple
yet standardized procedure which demonstrates useful
improvements in a routine activity e.g. walking. Thus the
primary objective of our study was to examine the potential
of the ESWT as a simple and practical tool to assess the
benefits of ambulatory oxygen. The aims were: (i) to
examine the sensitivity of the ESWT to ambulatory oxygen;
(ii) to investigate whether a newly developed, portable IPS
device (the HIPPY, Friday Medical, U.K.) had any
potential benefit when used in an ambulatory manner.
Method
PATIENTS
Ten patients (six males) with severe chronic obstructive
pulmonary disease (FEV1 5 40% predicted) were studied.
All were ex-smokers. The baseline characteristics of the# 2000 HARCOURT PUBLISHERS LTD
TABLE 1. Baseline characteristics and oxygen saturation at peak incremental shuttle walk
Patient Age Sex BS FEV1 PCO2 PcCO2 %ScO2 Medication %SpO2 ex
(1) (kPa) (kPa)
1 58 F 0?5 0?90 8?03 5?34 91 BD 81
2 62 M 1 0?35 8?32 5?64 91 BD, IS, LTOT 85
3 68 M 2 0?80 7?68 5?77 91 BD, —, LTOT 79
4 77 F 0 0?95 9?40 4?51 95 BD, IS, SBO2 83
5 70 M 0 0?55 6?62 7?07 85 BD, IS, LTOT 77
6 62 M 2 1?45 8?82 4?25 93 BD, IS, LTOT 86
7 55 M 3 0?50 9?96 5?51 95 BD, IS, LTOT 85
8 64 M 3 0?65 6?79 6?42 86 BD, IS, LTOT 72
9 58 F 2 0?40 7?92 6?22 91 BD, OS, LTOT 74
10 81 F 1 0?50 8?22 6?35 91 BD, IS 83
Median 63 — 1?5 0?60 8?13 5?71 91 82
(range) (58, 81) (0, 3) (0?35, 1?45) (6?62, 9?96) (4?25, 7?07) (85, 95) (72, 86)
Baseline characteristics measured at the first visit:- Borg breathlessness score at rest (BS), forced expiratory volume in 1 sec
(FEV1), earlobe capillary blood gases at rest (PcO2, PcCO2, %ScO2), non-invasive oxygen saturation at peak incremental
shuttle walk (finger pulse oximeter, %SpO2ex). Medications were long term oxygen therapy (LTOT), short burst oxygen
(SBO2), inhaled bronchodilator (BD), inhaled steroid (IS) and oral steroid (OS). The median (range) for FEV1 (l) at visits 2
and 3 were 0?55 l (0?35, 1?45) and 0?60 l (0?35, 1?50), respectively.
AMBULATORY OXYGEN AND VENTILATOR IN COPD 779group and exercise desaturation during an initial incre-
mental shuttle walk (ISWT) (11) are shown in Table 1. The
patients were recruited to the study following completion of
our 7 week outpatient pulmonary rehabilitation pro-
gramme. In order to blind the active and sham treatments
patients were informed, prior to consent, that the walk tests
would be repeated with two dierent inspiratory pressures,
and two dierent oxygen flows. The study had received
approval from the District Ethics Committee and written,
informed consent was given by all of the participants.
Patients were instructed to use their inhaled bronchodilator
within 1 h of their appointment time, otherwise there were
no alterations to prescribed medication.
STUDY DESIGN
The study involved three visits to the hospital. At each visit
the FEV1 and Borg score (12) for the degree of breath-
lessness at rest were recorded. At the first visit an ISWT, a
practice and a baseline ESWT were performed with the
patient breathing room air (without cylinder). At visit 2 the
ESWT was performed with one of the treatments (oxygen
or IPS) allocated randomly. At visit 3 the ESWT was
repeated with the alternate treatment. Additionally, at visits
2 and 3, the ESWT was also repeated with the correspond-
ing sham treatment. The active treatments were IPS at
14 cmH2O (the HIPPY device) and ambulatory oxygen
(Sabre portable oxygen cylinder AAV 230, Sunrise Medical,
Wollaston, U.K.) at 2 lmin71 via nasal cannulae. The sham
treatments were IPS 5 8 cmH2O and, for oxygen, patients
carried the cylinder with nasal cannulae in situ and the flow
regulator switched to the o position. Sham and active
treatments were single blinded and presented in randomizedorder at each visit with a 30min rest period between walk
tests.
FIELD WALK TESTS AND MEASUREMENTS
The ESWT and the calculation of the exercise intensity
(walking speed) has been described previously (10). Briefly,
the ESWT consists of a 10 m shuttle course around which
the patient walks in time to an audio signal from a cassette
tape. The endurance speed remains constant, (following a
90 sec slower, warm-up), and patients are instructed to walk
without stopping for as long as possible until too breathless
or tired to continue. The endurance speed for each patient
was related to 85% of the predicted oxygen uptake
calculated from the total distance walked during the
incremental shuttle test.
The duration of walking, at the endurance speed, was
recorded. In addition, the reason for exercise termination
and Borg scores for breathlessness (0–10) and perceived
exertion (6–20) were recorded at the end of every test. The
oxygen saturation (%SpO2) was measured from a finger
pulse oximeter (Pulsox-3i, Minolta, Sunrise Medical, U.K.)
at rest and at the end of each exercise test. Earlobe capillary
blood gases were also measured at rest and upon immediate
completion of walking with the active treatments.
Ambulatory oxygen
The ambulatory oxygen cylinder used gaseous oxygen and
had a fill capacity of 200 l, which provided approximately
100min usage at a flow of 2 lmin71. The cylinder was
carried over the shoulder in a carry case (2?8 kg when full).
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The HIPPY is a light weight, portable, pressure cycled
ventilator. The inspiratory pressure can be adjusted from5
8 cmH2O to 20 cmH2O. The device has three operating
modes (timed, triggered/timed and triggered only). For this
study all breaths were patient triggered using the minimum
expiratory and inspiratory trigger settings (0?5 cmH2O).
Positive end-expiratory pressure (PEEP) was set to the
lowest setting (5 3 cmH2O), and the expiratory and
inspiratory time adjusted for each patient. The ventilator
was powered from a 12V rechargeable battery and the
whole device was carried in a loose fitting, lightweight
backpack (total weight 2?1 kg).
Prior to using the HIPPY ventilator, patients were
instructed in its use, and received a prolonged period of
practice with the machine. A full face-mask was used which
was held in place with an adjustable head strap. An
exhalation valve was connected between the mask in/outlet
and the patient circuit. During the practice sessions the
inspiratory pressure was increased gradually to allow
patients to adapt to the sensation, with a final setting of
14 cmH2O used during the active treatment walk.
STATISTICAL ANALYSIS
Descriptive data are presented as median and range, and
comparative data presented as mean and standard error
(SE). Treatments were compared using ANOVA, and
dierences expressed as mean and 95% confidence intervals
(95% CI). Relationships between oxygen saturation and the
duration of the ESWT were examined using the Pearson









1 137 71 83
2 141 131 141
3 194 128 102
4 198 98 105
5 86 30 30
6 151 58 58
7 240 110 112
8 190 105 110
9 150 54 54
10 235 50 50
Mean (SE) 172 (15) 84 (11) * 84 (11) * 7
BS 4 (0?4) 5 (0?4) 5 (0?4)
PE 12 (0?4) 13(1?0) 13(1?0)
*P50?05 c.f. baseline walk
Individual and mean endurance shuttle walk times (sec), and %
Borg scores for breathlessness (BS) and perceived exertion (PE)Results
Ten patients completed all parts of the study with a mean
duration between visits of 4 days (2). The mean warm-up
speed of the ESWT was 1?95 kmh71 (0?47) (duration
90 sec) and the mean endurance speed was 3?06 kmh71
(0?61). The individual results for the duration of the ESWT,
the mean and % change from the baseline walk (without
cylinder) are shown in Table 2. The mean dierences and
95% confidence intervals, with all treatments compared to
the baseline walk, are illustrated in Fig. 1.
THE ESWT WITH OXYGEN
There was a large and significant improvement in the
ESWT duration with the ambulatory oxygen compared to
the baseline and the sham oxygen walks. The mean (95%
CI) increase for the oxygen ESWT compared to the baseline
walk was 70 sec (24, 115), and compared to the sham
oxygen walk was 91 sec (53, 129). The duration of the
ESWT with oxygen translates to a mean walking distance
of 209m (SD 76), compared to the baseline ESWT distance
of 147m (SD 49). There was only one patient who did not
show an improvement with oxygen (patient 10). This was
an 81 year old female patient who reported that the weight
of the cylinder had impaired her performance. There was a
slight decrease in the mean duration of the sham oxygen
walk, however the dierences, compared to the baseline
walk, did not reach significance [721 sec (6, 749)].
The mean value of the %SpO2 at the end of the oxygen
walk was significantly higher than the HIPPY and the
baseline walks, (P50?05) (Table 3). Despite walking
significantly further, patients reported similar levels of









739 104 257 88
0 138 206 46
747 217 308 59
747 119 254 28
765 88 240 179
762 140 175 16
753 196 334 39
742 214 309 63
764 143 156 4
779 150 178 724
50 (7) 150 (12) 242 (20) * 50 (18)
4 (0?3) 4 (0?4)
12(0?5) 12(0?4)
change from baseline (for active treatments). The mean (SE)
are also shown.
AMBULATORY OXYGEN AND VENTILATOR IN COPD 781oxygen walk to those reported at the end of the baseline
walks.
There were no significant relationships between the
duration of the baseline ESWT, or the duration of the
oxygen ESWT and the measurements of end exercise
%SpO2, change in %SpO2 (rest — exercise), FEV1, age or
baseline PcO2. The main reason for exercise termination
during the baseline ESWT was breathlessness and this
remained unchanged for all treatments.
THE ESWT WITH THE HIPPY
All the patients completed the warm-up phase of the ESWT
with the HIPPY and reported feeling comfortable with the
ventilator at the lower level of exertion. During the faster
endurance speed there was a large decrease in the duration
of walking with the HIPPY. Additionally, there was aFIG. 1. Mean dierences and 95% confidence intervals
between the baseline endurance shuttle walk and each
treatment.
TABLE 3. End of walk oxygen saturation and capillary blood ga
Status Rest Baseline shamH
Oximetry
%SpO2 92?0 (1?0) 80?0 (2?0) 78?8
mean dierence (95% CI) 70?9(7
CBG
PcO2 (kPa) 8?12 (0?36) — —
PcCO2 (kPa) 5?78 (0?32) — —
* P50?05 c.f. baseline ESWT. ^P50?05 c.f. HIPPY
Mean (SE) oxygen saturation (%SpO2) and earlobe capillary blo
intervals for the %SpO2 between the baseline walk and each oftendency for higher Borg scores (Table 2). There were no
significant dierences in the %SpO2 at the end of the
HIPPY walk and the baseline walk (Table 3). There was a
tendency for lower PcCO2 values at the end of the HIPPY
walk compared to the oxygen walk, but this was not
significant (Table 3).
Discussion
The aim of this study was to assess the sensitivity of the
ESWT to acute ambulatory oxygen and to investigate the
usefulness of the HIPPY device for ambulatory use. We
found the test was able to distinguish between the active
and sham oxygen treatments in the majority of patients,
and also detected that the HIPPY ventilator was inade-
quate at higher ventilatory demands. There was a small,
though insignificant, dierence between the baseline and
sham oxygen walks suggesting the cylinder weight hindered
exercise performance and masked any placebo derived
benefit that may have been present.
The mean improvement in distance walked during the
oxygen ESWT, compared to the baseline walk, was 62m
(95% CI 23,101m), in a mean total test time of 4min
(endurance walking). The improvement compares well with
the results from other studies which have utilized a range of
timed walk tests. Roberts (13) measured an increase of 24m
in the 6min walk (O2 2 lmin
71) with patients carrying the
same type of cylinder as the current study. Lock (6)
recorded a 16% improvement and Leach (2), using a liquid
oxygen system of similar weight, measured a 2% improve-
ment in the 6min walk. Waterhouse (4) measured an
improvement of 20m during a 5min test with oxygen at
2 lmin71, and Leggett (5) demonstrated an increase of
34m, using a 12min test and a wheeled liquid oxygen
system. Whilst these improvements may be statistically
significant, recent work has indicated that a change of 54 m
or more is required to constitute a clinically significant
eect (14). The large improvement in the current study may
reflect dierences between study populations and protocols,
however it also highlights the dierence in the nature of the
ESWT compared with the time limited walking tests.
During the 6 and 12min tests the patient can vary speedses
IPPY HIPPY O2 (2 lmin
71) sham O2
(2?3) 80?1 (2?0) 85?0 (2?0)* 79?9 (2?3)
4?0, 2?2) 0?4(73?5, 4?3) 5?1(0?6, 9?6) 0?2(2?7, 3?1)
5?78 (0?26) 7?20 (0?40)^ —
6?28 (0?32) 6?75 (0?40) —
od gases (CBG). The mean dierences and 95% confidence
the treatments are also shown.
782 S. M. REVILL ET AL.within and between tests, whereas the ESWT maintains a
constant speed and presents the same exercise challenge at
repeat testing. Additionally, the ESWT is a continuous test
whilst the 6 and 12min tests permit the patient to stop when
desired.
Leach (2) suggested that a short burst of intensive
exercise without stopping is more sensitive to the eects of
oxygen than the self-paced timed tests. The ESWT is a fully
standardized endurance test which presents the same
exercise intensity, relative to maximum capacity, to all
patients. The mean improvement for the group was large,
however there was a degree of individual variability, a
finding which has been demonstrated with other field tests
(1,2,6). Leach (2) recommended that portable oxygen
should only be considered if an individual patient shows a
50% improvement in exercise ability, and Lock (6)
suggested a 10% improvement. The U.K. Guidelines (7)
suggest that a 10% improvement in walk distance and/or
breathlessness score should be demonstrated before ambu-
latory oxygen is prescribed. In our study six of the patients
on LTOT, and two of those not using LTOT, had an
improvement of 415%. A larger study is required to
determine what would be the minimum clinically important
change for the prescription of oxygen, and our preliminary
findings suggest that improvements may not be just limited
to those on LTOT.
Although we did not titrate the oxygen flow to abolish
the exercise desaturation we demonstrated an eect with
continuous flow oxygen at 2 lmin71. The oxygen more than
compensated for the negative eect of the cylinder weight
for the majority of patients. Additionally, the subjective
ratings of breathlessness and perceived exertion, recorded
at the end of the oxygen ESWT, were not significantly
dierent from the baseline walks, thus patients were able to
exercise for longer with the same degree of breathlessness.
The oxygen was turned o during the sham limb. As far as
we are aware no patient suspected the absence of gas flow
during the sham walk and the single blind nature of the
study was maintained. This compromise was adopted
because of the diculty in obtaining a similar type of
cylinder filled with air. We felt this was more practicable
and less obtrusive than the operator walking alongside the
patient pushing the cylinder.
The use of ventilatory support within the confines of a
pulmonary rehabilitation programme may enable exercise
training to be tolerated for longer periods by the breathless
patient and possibly allow skeletal muscle training above
the anaerobic threshold (15,16). The development of a
machine which is light enough to allow unrestricted
ambulation, and which could be used both in and outside
the patient’s home, would increase flexibility of treatment
and have potential benefits for quality of life. The HIPPY
ventilator represents a laudable attempt at such a machine.
Although a lightweight machine has been achieved, the
results from the ESWT suggest that the output was
adequate only at rest and during the lowest levels of
exertion.
Our experience with the HIPPY ventilator supports the
findings of Highcock (17). The authors found a significant
decrease in the distance walked with the HIPPY and themeasured flow output was insucient at higher ventilatory
demand. In the current study patients found the HIPPY
light and easy to manipulate, and quickly adapted to the
machine (all were naive to IPS). Since the HIPPY was
readily tolerated and required only one practice session we
would suggest that a more powerful machine (i.e. greater
flow output) is considered for future development.
In conclusion, the ESWT was sensitive to ambulatory
oxygen and was able to distinguish between sham and
active treatments. The ESWT also highlighted the limita-
tions of the HIPPY machine for ambulatory use and higher
levels of ventilation. With ambulatory oxygen there were
significant improvements in the duration and distance
walked which more than compensated for the negative
eects of the cylinder weight. Unlike the 6min walk, the
standardized ESWT presents the same exercise challenge
upon repeat testing and, in this study, detected large
improvements with oxygen in the majority of patients. The
ESWT was sensitive to the eects of the dierent treatment
modalities and could provide the basis of a standardized
assessment for the prescription of ambulatory oxygen.
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